Spanish integrated oil and gas company Cepsa plans to hike capital expenditure to €3.6bn ($3.8bn) in 2023-25, an increase of over 90pc compared with the previous three years.
The planned rise in investment comes after the firm delivered a 66pc increase in profit last year, with nearly half of the spending over the next three years to be earmarked for the company's sustainable businesses including biofuels, renewables and green hydrogen. The budget is being expanded despite the fact Cepsa has agreed to sell almost half of its upstream production capacity. The company announced this week the sale of its core Abu Dhabi upstream oil assets to TotalEnergies for an undisclosed sum.
Cepsa today reported a profit of €1.1bn for 2022, up from €661mn in 2021. Excluding inventory valuation effects and one-off items, the firm's profit more than doubled to €790mn from €310mn. The improved financial performance reflects a 12pc increase in oil production to 83,000 b/d and a 43pc increase in average prices for its crude to $97.70/bl over the period.
Cepsa's upstream business was its main earnings driver in 2022, accounting for 64pc of adjusted earnings before interest, taxes, depreciation and amortisation (Ebitda). The firm said it expects the loss of future cash flows arising from the sale of the Abu Dhabi assets to be quickly recovered by expanding other businesses, but it did not elaborate.
In the downstream sector, Cepsa reported average refining margins at its Spanish refineries of $9.6/bl in 2022, up from from $3.7/bl in 2021. In October-December margins more than doubled on the year to $8.7/bl. The company has been reporting refining margins over $10/bl in the first two months of 2023 but volatility in oil product prices and inflation could pressure crack spreads later in the year, according to chief financial officer Carmen del Pablo.
Cepsa's detergent, phenol and acetone-focused chemicals business reported a 15pc fall in sales volumes to 2.49mn t in 2022 compared with 2021 on the back of lower demand and margins for phenol. The company's core linear alkylbenzene (LAB) detergent feedstock business reported a more resilient performance during the global downturn in petrochemical margins in the fourth quarter. LAB sales were 162,000t in October-December, up by 7pc on the quarter and down by just 1pc on the year.

